skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Refinado por: Nome da Publicação: Journal Of Clinical Oncology remover nível superior: Revistas revisadas por pares remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Effect of lapatinib on accumulation of inactive HER2 at the cell membrane and on antibody-dependent cellular cytotoxicity (ADCC) mediated by trastuzumab: A novel mechanism for the enhanced effects of combined anti-HER2 therapy
Effect of lapatinib on accumulation of inactive HER2 at the cell membrane and on antibody-dependent cellular cytotoxicity (ADCC) mediated by trastuzumab: A novel mechanism for the enhanced effects of combined anti-HER2 therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of lapatinib on accumulation of inactive HER2 at the cell membrane and on antibody-dependent cellular cytotoxicity (ADCC) mediated by trastuzumab: A novel mechanism for the enhanced effects of combined anti-HER2 therapy

Scaltriti, M. ; Verma, C. ; Guzman, M. ; Jimenez, J. ; Parra, J. ; Pedersen, K. ; Landolfi, S. ; Ramon y Cajal, S. ; Arribas, J. ; Baselga, J.

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.3594-3594 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
2
Phase II, noncomparative, open label, multicenter, study of osimertinib, in patients with locally advanced or metastatic EGFR mutated, T790M undetectable or unknown non-small cell lung cancer (Stage IIIB-IV) after no immediate prior EGFR TKI (OSIRIS study)
Phase II, noncomparative, open label, multicenter, study of osimertinib, in patients with locally advanced or metastatic EGFR mutated, T790M undetectable or unknown non-small cell lung cancer (Stage IIIB-IV) after no immediate prior EGFR TKI (OSIRIS study)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II, noncomparative, open label, multicenter, study of osimertinib, in patients with locally advanced or metastatic EGFR mutated, T790M undetectable or unknown non-small cell lung cancer (Stage IIIB-IV) after no immediate prior EGFR TKI (OSIRIS study)

Soto Parra, Hector J. ; Noto, Laura ; Verderame, Francesco ; Galetta, Domenico ; Barbieri, Vito ; Ferrau, Francesco ; Migliorino, Maria Rita ; Catino, Annamaria ; Aiello, Marco M. ; Capelletto, Enrica ; Ricciardi, Serena ; Spinnato, Francesca ; Tassone, Pierfrancesco ; Morelli, Anna Maria ; Latteri, Fiorenza ; Gozzo, Lucia ; Valerio, Oriana ; Avola, Rossana ; Novello, Silvia

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e21116-e21116 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
3
Excision repair cross complementation group 1 (ERCC-1) gene polymorphisms and response to nivolumab in advanced non-small cell lung cancer (NSCLC)
Excision repair cross complementation group 1 (ERCC-1) gene polymorphisms and response to nivolumab in advanced non-small cell lung cancer (NSCLC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Excision repair cross complementation group 1 (ERCC-1) gene polymorphisms and response to nivolumab in advanced non-small cell lung cancer (NSCLC)

Aiello, Marco M. ; Vigneri, Paolo Giovanni ; Bruzzi, Paolo ; Verderame, Francesco ; Paratore, Sabrina ; Restuccia, Nunzio ; Albanese, Valeria ; Soto Parra, Hector J.

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.3032-3032 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
4
Malignant pleural mesothelioma (MPM) genomic profile in the randomized phase II RAMES Study
Malignant pleural mesothelioma (MPM) genomic profile in the randomized phase II RAMES Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Malignant pleural mesothelioma (MPM) genomic profile in the randomized phase II RAMES Study

Pagano, Maria ; Gnoni, Roberta ; Bonelli, Candida ; Zanelli, Francesca ; Garassino, Marina Chiara ; Ceresoli, Giovanni Luca ; Pasello, Giulia ; Tiseo, Marcello ; Soto Parra, Hector J. ; Grosso, Federica ; Zucali, Paolo Andrea ; Torricelli, Federica ; Pinto, Carmine

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.8547-8547 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
5
Randomized phase II study on gemcitabine with or without ramucirumab as second-line treatment for advanced malignant pleural mesothelioma (MPM): Results of Italian Rames Study
Randomized phase II study on gemcitabine with or without ramucirumab as second-line treatment for advanced malignant pleural mesothelioma (MPM): Results of Italian Rames Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized phase II study on gemcitabine with or without ramucirumab as second-line treatment for advanced malignant pleural mesothelioma (MPM): Results of Italian Rames Study

Pagano, Maria ; Ceresoli, Giovanni Luca ; Zucali, Paolo Andrea ; Pasello, Giulia ; Garassino, Marina Chiara ; Grosso, Federica ; Tiseo, Marcello ; Soto Parra, Hector J. ; Zanelli, Francesca ; Cappuzzo, Federico ; Grossi, Francesco ; de Marinis, Filippo ; Pedrazzoli, Paolo ; Gnoni, Roberta ; Bonelli, Candida ; Berselli, Annalisa ; Boni, Luca ; Normanno, Nicola ; Pinto, Carmine

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.9004-9004 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
6
Baseline and early change of systemic inflammation index (bSII and ΔSII) as prognostic factors in metastatic renal cell carcinoma (mRCC) patients treated with Nivolumab: Final results of the Meet-URO 15 (I-BIO-REC) study
Baseline and early change of systemic inflammation index (bSII and ΔSII) as prognostic factors in metastatic renal cell carcinoma (mRCC) patients treated with Nivolumab: Final results of the Meet-URO 15 (I-BIO-REC) study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Baseline and early change of systemic inflammation index (bSII and ΔSII) as prognostic factors in metastatic renal cell carcinoma (mRCC) patients treated with Nivolumab: Final results of the Meet-URO 15 (I-BIO-REC) study

Rebuzzi, Sara Elena ; Atzori, Francesco ; Di Napoli, Marilena ; Stellato, Marco ; Messina, Marco ; Chiellino, Silvia ; Vignani, Francesca ; Cavo, Alessia ; Soto Parra, Hector J. ; Roviello, Giandomenico ; Prati, Veronica ; Bimbatti, Davide ; De Giorgi, Ugo ; Bersanelli, Melissa ; Paolieri, Federico ; Zucali, Paolo Andrea ; Fantinel, Emanuela ; Procopio, Giuseppe ; Signori, Alessio ; Fornarini, Giuseppe

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.5072-5072 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
7
A phase II, noncomparative, open label, multicentre, study of AZD9291 in patients with locally advanced or metastatic EGFR mutated “T790M undetectable or unknown” non-small cell lung cancer (stage IIIB-IV) after no immediate prior EGFR TKI (OSIRIS study)
A phase II, noncomparative, open label, multicentre, study of AZD9291 in patients with locally advanced or metastatic EGFR mutated “T790M undetectable or unknown” non-small cell lung cancer (stage IIIB-IV) after no immediate prior EGFR TKI (OSIRIS study)
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II, noncomparative, open label, multicentre, study of AZD9291 in patients with locally advanced or metastatic EGFR mutated “T790M undetectable or unknown” non-small cell lung cancer (stage IIIB-IV) after no immediate prior EGFR TKI (OSIRIS study)

Soto Parra, Hector J. ; Noto, Laura ; Galetta, Domenico ; Ferraú, Francesco ; Gebbia, Vittorio ; Tassone, Pierfrancesco ; Verderame, Francesco ; Aiello, Marco M. ; Latteri, Fiorenza ; Novello, Silvia

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.TPS9107-TPS9107 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
8
Multicenter study of the evaluation of eribulin (E) use in Sicily in metastatic breast cancer (MBC): A prospective registry (VESPRY trial)
Multicenter study of the evaluation of eribulin (E) use in Sicily in metastatic breast cancer (MBC): A prospective registry (VESPRY trial)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Multicenter study of the evaluation of eribulin (E) use in Sicily in metastatic breast cancer (MBC): A prospective registry (VESPRY trial)

Adamo, Vincenzo ; Ricciardi, Giuseppina ; Giuffrida, Dario ; Scandurra, Giuseppa ; Russo, Antonio ; Blasi, Livio ; Spadaro, Pietro ; Lucenti, Antonio ; Soto Parra, Hector J. ; Savarino, Antonino ; Ferraú, Francesco ; Zerilli, Filippo ; Verderame, Francesco ; Butera, Alfredo ; Franchina, Veronica ; Cottini, Lorenzo ; Fedele, Guido ; Caruso, Michele

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e12565-e12565 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
9
Efficacy of mitomycin C plus a fluoropyrimidine in pretreated patients with metastatic colorectal cancer eligible to regorafenib: Results of a retrospective study
Efficacy of mitomycin C plus a fluoropyrimidine in pretreated patients with metastatic colorectal cancer eligible to regorafenib: Results of a retrospective study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy of mitomycin C plus a fluoropyrimidine in pretreated patients with metastatic colorectal cancer eligible to regorafenib: Results of a retrospective study

Martorana, Federica ; Cordio, Stefano Sergio ; Bordonaro, Roberto ; Vigneri, Paolo Giovanni ; Novello, Giuseppe ; Aiello, Marco M ; Martines, Concetta ; Soto Parra, Hector J.

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e14661-e14661 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
10
Clinicopathological features of patients with malignant mesothelioma in a multicenter, retrospective study
Clinicopathological features of patients with malignant mesothelioma in a multicenter, retrospective study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinicopathological features of patients with malignant mesothelioma in a multicenter, retrospective study

Mencoboni, Manlio ; Filiberti, Rosa ; DelCorso, Lisette ; Bruzzone, Andrea ; Grosso, Federica ; Pasello, Giulia ; Favaretto, Adolfo G. ; Soto Parra, Hector J. ; Taveggia, Paola ; Perrino, Matteo ; Zucali, Paolo Andrea ; Ceresoli, Giovanni Luca

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e12651-e12651 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Data de Publicação 

De até
Refinar
  1. Antes de2009  (3)
  2. 2009Até2010  (2)
  3. 2011Até2012  (2)
  4. 2013Até2015  (6)
  5. Após 2015  (8)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.